.alpha.-Aminoboronic acid peptides

.alpha.-Aminobutyric acid transaminase inhibitors

.alpha.-aminoketone derivatives

.alpha.-and .beta.-amino acid hydroxyethylamino sulfonamides use

.alpha.-aryl-.alpha.-hydroxy-.beta.-imidazolinyl-propionamides

.alpha.-Aryl-.alpha.-pyridylalkanoic acid derivatives, process f

.alpha.-aryl-N-alkylnitrones and pharmaceutical compositions con

.alpha.-arylacrylates substituted by a heterocyclic radical, and

.alpha.-arylacrylates substituted by a heterocyclic radical, and

.alpha.-arylacrylates substituted by a heterocyclic radical, and

.alpha.-arylacrylates substituted by a trifluoromethylpyrimidiny

.alpha.-arylacrylic acid derivatives, their preparation and thei

.alpha.-arylacrylic acid derivatives, their preparation and thei

.alpha.-arylacrylic acid derivatives, their preparation and use

.alpha.-branched anilines, toluenes, and analogs thereof as fact

.alpha.-fluoro-.alpha.-(1,2,3-triazolyl)-phenylmethyl derivative

.alpha.-fluoro-.alpha.-1-(1,2,4-triazolyl)-phenylmethyl derivati

.alpha.-fluoro-.alpha.-tetrazolyl-phenylmethyl derivatives usefu

.alpha.-glucosidase inhibitor, composition principally comprisin

.alpha.-glucosidase inhibitors